ARCHIVES

FDA Roundup: Public Citizen Uses Logic of FDA’s Critical Path to Challenge Decision On Anti-Obesity Drug.

This article is from The Cancer Letter archive.

Vol. 32 No. 22 | June 9, 2006

Download PDF Visit The Full Archive

Related Articles

Scientists, Advocates Voice Objections To von Eschenbach’s Conflicts, 2015.

November 22, 2006

Klausner, Nathan Discuss Challenge of Cancer Research In the “Post-Genome World”

January 15, 1999

User Fees Proposed For FDA Oversight Services; Industry Groups Call It “Tax On Innovations”

January 20, 1989

ASCO, COA Present Plans For Cancer CareBeyond the Fee-For-Service Pay Structure

January 24, 2014

HPV Can Affect Response To Radiation Therapies

September 28, 2012

Advisors OK Planning Grants In Breast Cancer For Cancer Centers

July 9, 1993